Semaglutide vs. Tirzepatide: Which Is Right for You?

The Core Difference: One Pathway vs. Two

Semaglutide is a GLP-1 receptor agonist — it activates one hormone pathway (GLP-1) that regulates appetite, gastric emptying, and insulin secretion.

Tirzepatide is a dual GIP/GLP-1 receptor agonist — it activates two hormone pathways simultaneously. GIP (Glucose-dependent Insulinotropic Polypeptide) is another gut hormone that works alongside GLP-1 to amplify insulin response and further reduce appetite. This dual action is why tirzepatide tends to produce greater average weight loss than semaglutide.

Clinical Results: How Do They Compare?

Head-to-head clinical trials (SURMOUNT-5, 2025) comparing tirzepatide directly to semaglutide found:

• Tirzepatide produced an average weight loss of ~20.2% of body weight at 72 weeks
• Semaglutide produced an average weight loss of ~13.7% of body weight at 72 weeks
• Tirzepatide users were 53% more likely to achieve at least 25% weight loss

That said, individual results vary significantly. Many people achieve excellent results with semaglutide, and some respond better to it than to tirzepatide.

Side Effect Profile

Both medications share a similar side effect profile, as they work on the same biological systems:

• Nausea, vomiting, diarrhea, and constipation — most common early on and during dose increases
• Reduced appetite and early satiety
• Fatigue, especially in the first few weeks

Tirzepatide tends to cause somewhat more gastrointestinal side effects at higher doses, though this varies by individual. Both medications use a gradual dose escalation protocol to minimize discomfort.

Quick Comparison

Which Should You Choose?

Neither medication is universally better — the right choice depends on your medical history, how your body responds, your goals, and your provider's clinical judgment. Some considerations:

• Start with semaglutide if you are new to GLP-1 therapy, want a well-established option with a longer track record, or are more sensitive to GI side effects.
• Consider tirzepatide if you have tried semaglutide with limited results, have higher weight loss goals, or want the strongest evidence-based option available.

A CalyHealth provider will review your intake and recommend the medication and starting dose best suited to you — and can adjust your plan over time based on your response.